RE:RE:Acumen Pharma Quarterly No meaniful news coming from them for probably quite some time. ACU 193 a one trick pony their only product, Phase 1 just wrapped after 2 years in the clinic, phase 2 expected to start in the second half of 2024. A long haul in clinic trials with many possible setbacks. They do seem to have a very qualified team with sound technical data it appears. Can't say i understand it! You have to give them credit raising cash $170 million at $16/share in 2021 and $130 milion at $7.75/share this summer.
Not suprized about the share price you don't get many investors excited after phase 1 results just provide confirmation you can keep going.
Short interest jumped from 150 K in June to 2 million in Sept/Oct,
What is Promis going to do with all of their Pony's AD, PD, ALS, Vaccine development, etc.